Zobrazeno 1 - 10
of 875
pro vyhledávání: '"Caroline M Tanner"'
Autor:
Tien Dam, Gennaro Pagano, Michael C. Brumm, Caroline Gochanour, Kathleen L. Poston, Daniel Weintraub, Lana M. Chahine, Christopher Coffey, Caroline M. Tanner, Catherine M. Kopil, Yuge Xiao, Sohini Chowdhury, Luis Concha-Marambio, Peter DiBiaso, Tatiana Foroud, Mark Frasier, Danna Jennings, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Thomas J. Montine, Kelly Nudelman, John Seibyl, Todd Sherer, Andrew Singleton, Diane Stephenson, Matthew Stern, Claudio Soto, Eduardo Tolosa, Andrew Siderowf, Billy Dunn, Tanya Simuni, Kenneth Marek, the Parkinson’s Progression Markers Initiative
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract The Neuronal alpha-Synuclein Disease (NSD) biological definition and Integrated Staging System (NSD-ISS) provide a research framework to identify individuals with Lewy body pathology and stage them based on underlying biology and increasing
Externí odkaz:
https://doaj.org/article/bcf123a33df949f9999736ef3c3dd94e
Autor:
Gina Shaw
Publikováno v:
Neurology Today. 21:8-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f56712ff3a5f44abdfefb4dc45c9b31c
https://doi.org/10.1097/01.nt.0000752844.66769.73
https://doi.org/10.1097/01.nt.0000752844.66769.73
Autor:
Alonso, Alvaro
Publikováno v:
Journal of Epidemiology and Community Health (1979-), 2006 Aug 01. 60(8), 735-735.
Externí odkaz:
https://www.jstor.org/stable/40794031
Autor:
Ibrahim Karabayir, Fatma Gunturkun, Liam Butler, Samuel M. Goldman, Rishikesan Kamaleswaran, Robert L. Davis, Kalea Colletta, Lokesh Chinthala, John L. Jefferies, Kathleen Bobay, G. Webster Ross, Helen Petrovitch, Kamal Masaki, Caroline M. Tanner, Oguz Akbilgic
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Little is known about electrocardiogram (ECG) markers of Parkinson’s disease (PD) during the prodromal stage. The aim of the study was to build a generalizable ECG-based fully automatic artificial intelligence (AI) model to predict PD risk
Externí odkaz:
https://doaj.org/article/4e8f19f1770648138b80720afaf358b7
Autor:
Caroline M. Tanner, Stanley N. Caroff, Andrew J. Cutler, William R. Lenderking, Huda Shalhoub, Véronique Pagé, Ericha G. Franey, Michael Serbin, Chuck Yonan
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-11 (2023)
Abstract Background Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with antipsychotic use. Data from RE-KINECT, a real-world study of antipsychotic-treated outpatients, were analyzed to assess the effec
Externí odkaz:
https://doaj.org/article/7624d1f68f3346d79bebd79e645eff49
Autor:
Charity G. Patterson, Elizabeth Joslin, Alexandra B. Gil, Wendy Spigle, Todd Nemet, Lana Chahine, Cory L. Christiansen, Ed Melanson, Wendy M. Kohrt, Martina Mancini, Deborah Josbeno, Katherine Balfany, Garett Griffith, Mac Kenzie Dunlap, Guillaume Lamotte, Erin Suttman, Danielle Larson, Chantale Branson, Kathleen E. McKee, Li Goelz, Cynthia Poon, Barbara Tilley, Un Jung Kang, Malú Gámez Tansey, Nijee Luthra, Caroline M. Tanner, Jacob M. Haus, Giamila Fantuzzi, Nikolaus R. McFarland, Paulina Gonzalez-Latapi, Tatiana Foroud, Robert Motl, Michael A. Schwarzschild, Tanya Simuni, Kenneth Marek, Anna Naito, Codrin Lungu, Daniel M. Corcos, The SPARX3-PSG Investigators
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-26 (2022)
Abstract Background To date, no medication has slowed the progression of Parkinson’s disease (PD). Preclinical, epidemiological, and experimental data on humans all support many benefits of endurance exercise among persons with PD. The key question
Externí odkaz:
https://doaj.org/article/76455c85f6a1412282dc3e5f90536c78
Publikováno v:
npj Parkinson's Disease, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Maintaining consistent levodopa benefits while simultaneously controlling dyskinesia can be difficult. Recently, an amantadine delayed release/extended release (DR/ER) formulation (Gocovri®) indicated for dyskinesia received additional FDA
Externí odkaz:
https://doaj.org/article/b1df00da4e004601b9e0f076c7438b58
Autor:
Rajesh Pahwa, Susan Fox, Robert A. Hauser, Stuart Isaacson, Judy Lytle, Reed Johnson, Lily Llorens, Andrea E. Formella, Caroline M. Tanner
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundThe Unified Dyskinesia Rating Scale (UDysRS) evaluates dyskinesia in patients with Parkinson's disease (PD). A minimal clinically important change (MCIC)—the smallest change in a treatment outcome that a patient considers important—rema
Externí odkaz:
https://doaj.org/article/60ab47d041314b1e880ed7fc676425fc
Autor:
Caroline M. Tanner, Steven R. Cummings, Michael A. Schwarzschild, Ethan G. Brown, E. Ray Dorsey, Alberto J. Espay, Nicholas B. Galifianakis, Samuel M. Goldman, Irene Litvan, Nijee Luthra, Nikolaus R. McFarland, Kyle T. Mitchell, David G. Standaert, Douglas C. Bauer, Susan L. Greenspan, James C. Beck, Kenneth W. Lyles
Publikováno v:
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract The Trial of Parkinson’s And Zoledronic acid (TOPAZ, https://clinicaltrials.gov/ct2/show/NCT03924414 ) is a unique collaboration between experts in movement disorders and osteoporosis to test the efficacy of zoledronic acid, an FDA-approve
Externí odkaz:
https://doaj.org/article/de1c2ed76f6f4436af9d6293955c5287